The Impact of Low Albumin Levels on the Severity of Acute Pulmonary Embolism and its Prognostic Significance
International Journal of Medical Science |
© 2023 by SSRG - IJMS Journal |
Volume 10 Issue 6 |
Year of Publication : 2023 |
Authors : Mais Zamlout, Mohammad Alkhayer, Ibrahim Sulaiman |
How to Cite?
Mais Zamlout, Mohammad Alkhayer, Ibrahim Sulaiman, "The Impact of Low Albumin Levels on the Severity of Acute Pulmonary Embolism and its Prognostic Significance," SSRG International Journal of Medical Science, vol. 10, no. 6, pp. 36-42, 2023. Crossref, https://doi.org/10.14445/23939117/IJMS-V10I6P106
Abstract:
Objective: To investigate the impact of low albumin levels on the severity of acute pulmonary embolism (PE) and its prognostic significance. Materials and Methods: A prospective cohort study was conducted on 65 patients admitted to the department of respiratory medicine and ICU at Tishreen University Hospital between 2021-2023. Data on age, gender, albumin levels, platelet count, WBC count, D-dimer, hemoglobin, creatinine clearance, right ventricular dilation, blood pressure, heart rate, and oxygen saturation ratio were collected at the presentation. Patients were followed up for 90 days. Independent t-tests and chi-square tests were used for comparison analysis, linear regression was used for exploring relationships, and Kaplan-Meier curves were used for survival analysis. Results: Patients with low albumin levels exhibited lower mean values of SPO2, blood pressure, heart rate, and hemoglobin, as well as higher SPESI scores and platelet counts and higher mortality percentages. Regression analysis showed that low albumin levels were a significant predictor of PE severity. Age, mean blood pressure and WBC count also significantly impacted SPESI scores. Survival analysis indicated that the majority of patients deteriorated between 17-20 days from diagnosis, with the low albumin levels group showing higher mortality rates. Conclusion: Low albumin levels are associated with increased severity and mortality in acute PE. Other factors such as age, blood pressure, and WBC count also play a significant role in predicting PE severity. Early identification and management of low albumin levels may improve outcomes in patients with acute PE.
Keywords:
Albumin, Pulmonary embolism, SPESI, Venous thrombosis.
References:
[1] Samuel Z Goldhaber, "Pulmonary Embolism," Lancet, vol. 363, no. 9417, pp. 1295-1305, 2004.
[CrossRef] [Publisher Link]
[2] John A. Heit, "Epidemiology of Venous Thromboembolism," Nature Reviews Cardiology, vol. 12, no. 8, pp. 464-474, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[3] Paul D. Stein et al., "Clinical Characteristics of Patients with Acute Pulmonary Embolism: Data from PIOPED II," The American Journal of Medicine, vol. 120, no. 10, pp. 871-879, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[4] Jeffrey A. Kline, and Christopher Kabrhel, "Emergency Evaluation for Pulmonary Embolism, Part 1: Clinical Factors that Increase Risk," The Journal of Emergency Medicine, vol. 48, no. 6, pp. 771-780, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[5] Stavros V Konstantinides et al., "2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Collaboration with the European Respiratory Society (ERS)," European Heart Journal, vol. 41, no. 4, pp. 543-603, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[6] Paul D. Stein et al., "Silent Pulmonary Embolism in Patients with Deep Venous Thrombosis: a Systematic Review," The American Journal of Medicine, vol. 123, no. 5, pp. 426-431, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[7] Burl R Don, and George Kaysen, "Serum Albumin: Relationship to Inflammation and Nutrition," Semin Dial, vol. 17, no. 6, pp. 432- 437, 2004.
[CrossRef] [Publisher Link]
[8] Cecilia Becattini, and Giancarlo Agnelli, "Risk stratification and management of acute pulmonary embolism," Hematology Am Soc Hematol Educ Program, vol. 2016, no. 1, pp. 404-412, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[9] David Jiménez et al., "Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients with Acute Symptomatic Pulmonary Embolism," Archives of Internal Medicine, vol. 170, no. 15, pp. 1383-1389, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[10] David Jiménez et al., "Derivation and Validation of Multimarker Prognostication for Normotensive Patients with Acute Symptomatic Pulmonary Embolism," American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 6, pp. 718-726, 2014.
[CrossRef] [Google Scholar] [Publisher Link]
[11] Stavros Konstantinides, "Clinical Practice, Acute Pulmonary Embolism," New England Journal of Medicine, vol. 359, no. 26, pp. 2804- 2813, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[12] Thomas Meyer et al., "Cardiac Troponin I Elevation in Acute Pulmonary Embolism is Associated with Right Ventricular Dysfunction," Journal of the American College of Cardiology, vol. 36, no. 5, pp. 1632-1636, 2000.
[Google Scholar] [Publisher Link]
[13] Frederikus A. Klok, Inge C. M. Mos, and Menno V. Huisman, "Brain-Type Natriuretic Peptide levels in the Prediction of Adverse Outcome in Patients with Pulmonary Embolism: A Systematic Review and Meta-Analysis," American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 4, pp. 425-430, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[14] Chuan Liu et al., "Prognostic Role of the Preoperative Neutrophil-to-Lymphocyte Ratio and Albumin for 30-day Mortality in Patients with Postoperative Acute Pulmonary Embolism," BMC Pulmonary Medicine, vol. 20, no. 1, p. 1-8, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[15] Gregory Piazza, and Samuel Z. Goldhaber, "Acute Pulmonary Embolism: Part I: Epidemiology and Diagnosis," Circulation, vol. 114, no. 2, pp. e28-e32, 2006.
[CrossRef] [Google Scholar] [Publisher Link]
[16] Mareike Lankeit et al., "Highly Sensitive Troponin T Assay in Normotensive Patients with Acute Pulmonary Embolism," European Heart Journal, vol. 31, no. 15, pp. 1836-1844, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[17] Drahomir Aujesky et al., "Derivation and validation of a Prognostic Model for Pulmonary Embolism," American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 8, pp. 1041-1046, 2005.
[CrossRef] [Google Scholar] [Publisher Link]
[18] Nils Kucher, and Samuel Z. Goldhaber, "Cardiac Biomarkers for Risk Stratification of Patients with Acute Pulmonary Embolism," Circulation, vol. 108, no. 18, pp. 2191-2194, 2003.
[CrossRef] [Google Scholar] [Publisher Link]
[19] Ary Ribeiro et al., "Echocardiography Doppler in Pulmonary Embolism: Right Ventricular Dysfunction as a Predictor of Mortality Rate," American Heart Journal, vol. 134, no. 3, pp. 479-487, 1997.
[CrossRef] [Google Scholar] [Publisher Link]
[20] Israel Gotsman et al., "Low Serum Albumin: A Significant Predictor of Reduced Survival in Patients with Chronic Heart Failure," Clinical Cardiology, vol. 42, no. 3, pp. 365-372, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[21] Tamara B. Horwich et al., "Albumin Levels Predict Survival in Patients with Systolic Heart Failure," American Heart Journal, vol. 155, no. 5, pp. 883-889, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[22] Scott Hoskin BPharm et al., "Incidence and Impact of Hypoalbuminaemia on Outcomes Following Acute Pulmonary Embolism," Heart, Lung and Circulation, vol. 29, no. 2, pp. 280-287, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[23] Hesham R. Omar et al., "Association of Serum Albumin and Severity of Pulmonary Embolism," Medicina, vol. 56, no. 1, pp. 1-9, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[24] Maciej Kostrubiec et al., "Biomarker-Based Risk Assessment Model in Acute Pulmonary Embolism," European Heart Journal, vol. 26, no. 20, pp. 2166-2172, 2005.
[CrossRef] [Google Scholar] [Publisher Link]
[25] D. Jiménez et al., "Troponin I and Risk Stratification of Patients with Acute Nonmassive Pulmonary Embolism," European Respiratory Journal, vol. 31, no. 4, pp. 847-853, 2008.
[CrossRef] [Google Scholar] [Publisher Link]